HRTX icon

Heron Therapeutics

174 hedge funds and large institutions have $321M invested in Heron Therapeutics in 2022 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 57 increasing their positions, 55 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more ownership

Funds ownership:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding:

35% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 26

48% less capital invested

Capital invested by funds: $621M → $321M (-$299M)

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
174
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.19M
Puts
$232K
Net Calls
Net Calls Change

Top Buyers

1 +$28.3M
2 +$9.5M
3 +$2.35M
4
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
+$2.12M
5
BlackRock
BlackRock
New York
+$1.78M

Top Sellers

1 -$20.1M
2 -$5.5M
3 -$3.64M
4
Goldman Sachs
Goldman Sachs
New York
-$2.8M
5
Millennium Management
Millennium Management
New York
-$2.71M
Name Holding Trade Value Shares
Change
Change in
Stake
76
$149K
77
$147K
78
$144K
79
$144K
80
$134K
81
$133K
82
$128K
83
$124K
84
$123K
85
$122K
86
$120K
87
$119K
88
$116K
89
$114K
90
$110K
91
$108K
92
$100K
93
$98K
94
$96.6K
95
$93K
96
$89K
97
$84K
98
$77K
99
$76K
100
$76K